Phosphorus Metabolism Disorders - 25 Studies Found
Completed |
: Dietary Phosphate and Serum Phosphorus : Phosphorus Metabolism Disorders : 2015-04-22 |
Not yet recruiting |
: The Efficacy of Niacin on Hyperphosphatemia in Patients Undergoing Haemodialysis : Hyperphosphatemia : 2017-05-21 :
|
Recruiting |
: Decreasing Intakes & Absorption of Phosphorus in Haemodialysis Patients Through Food Choices :
: 2017-04-04 : |
Not yet recruiting |
: Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients : Hyperphosphatemia : 2017-03-01 : Drug: Ferric Citrate One to two tablets of Ferric Citrate phosphorus binder administered by mouth before |
Recruiting |
: Behavioral Management of Phosphorus in Hemodialysis Patients :
: 2016-10-17 :
|
Recruiting |
: Nicotinic Acid in Hemodialysis Patients With Hyperphosphatemia : Hyperphosphatemia : 2016-07-14 :
|
Recruiting |
: An Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia : Hyperphosphatemia : 2016-02-17 :
|
Recruiting |
: Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD) : Hyperphosphatemia : 2016-02-09 : Drug: sucroferric oxyhydroxide The non-interventional design allows the observation of patients in a bro |
Completed |
: Dose Finding Study to Treat High Phosphate Levels in the Blood. : Hyperphosphatemia : 2014-03-06 :
|
Completed |
: The Effect of Magnesium Oxide on Plasma Phosphate in Hemodialysis Patients : Hyperphosphatemia : 2013-05-04 : Drug: Mg Oxide 250 mg orally for 4 weeks Other Name: |